drugset / Trial / NCT00202163

ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction

NCT00202163

Phase 2 Completed 120 enrolled Queen's University
RandomizedParallel-groupDouble-blindTreatment

Summary

Androgen deficiency in the aging male is poorly understood. The objective of this study will be to determine the role of testosterone and DHEA in enhancing sexual interest and sexual performance.

Timeline

Start
2006-12
Primary completion
2007-07
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydroepiandrosterone Other / unclassified 50 mg
Subject Testosterone Small molecule 80 mg

Indications